Log In
Print this Print this

Campath-1H, alemtuzumab (Lemtrada, MabCampath, Campath)

Also known as: MabCampath-1H alemtuzumab (LDP-03)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHumanized mAb against CD52
Molecular Target CD52
Mechanism of ActionBinds CD52; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today